[{"Assets_0_Q3_USD":2603130000.0,"CommonStockSharesOutstanding_0_Q3_shares":48200257.0,"EarningsPerShareBasic_1_Q3_USD":0.58,"EarningsPerShareBasic_3_Q3_USD":1.8,"EarningsPerShareDiluted_1_Q3_USD":0.57,"EarningsPerShareDiluted_3_Q3_USD":1.79,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":73665000.0,"NetIncomeLoss_1_Q3_USD":27830000.0,"NetIncomeLoss_3_Q3_USD":86599000.0,"StockholdersEquity_0_Q3_USD":1914426000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48534000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":48339000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":48181000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":48130000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]